Last updated on November 2017

ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer NeoAdjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III Study


Brief description of study

ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer NeoAdjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III Study

Detailed Study Description

You are being asked to take part in this study because you are a postmenopausal woman with early stage breast cancer. This means that the cancer has not obviously spread to other parts of your body and is potentially curable. In addition, your breast cancer is highly positive for estrogen receptor, a protein that makes the cancer grow in the presence of the female hormone estrogen.

Clinical Study Identifier: TX8051

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Pamela Treas

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington, KY USA
  Connect »